Publications of A. Pfennig

Wegerer, M.; Adena, S.; Pfennig, A.; Czamara, D.; Sailer, U.; Bettecken, T.; Mueller-Myhsok, B.; Modell, S.; Ising, M.: Variants within the GABA transaminase (ABAT) gene region are associated with somatosensory evoked EEG potentials in families at high risk for affective disorders. PSYCHOLOGICAL MEDICINE 43 (6), pp. 1207 - 1217 (2013)

Kohli, M. A.; Salyakina, D.; Pfennig, A.; Lucae, S.; Horstmann, S.; Menke, A.; Kloiber, S.; Hennings, J.; Bradley, B. B.; Ressler, K. J. et al.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.; Binder, E. B.: Association of Genetic Variants in the Neurotrophic Receptor-Encoding Gene NTRK2 and a Lifetime History of Suicide Attempts in Depressed Patients. Archives of General Psychiatry 67 (4), pp. 348 - 359 (2010)

Beesdo, K.; Höfler, M.; Leibenluft, E.; Lieb, R.; Bauer, M.; Pfennig, A.: Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life. Bipolar Disorders 11 (6), pp. 637 - 649 (2009)

Binder, E. B.; Künzel, H. E.; Nickel, T.; Kern, N.; Pfennig, A.; Majer, M.; Uhr, M.; Ising, M.; Holsboer, F.: HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology 34 (1), pp. 99 - 109 (2009)

Ising, M.; Adena, S.; Binder, E.; Pfennig, A.; Schalling, M.; Mueller-Myhsok, B.; Modell, S.; Holsboer, F.: Genetic determinants of neurobiological vulnerability markers in depression. European Psychiatry 23 (Suppl. 2), p. S9 - S9 (2008)

Ising, M.; Horstmann, S.; Kloiber, S.; Lucae, S.; Binder, E. B.; Kern, N.; Künzel, H.; Pfennig, A.; Uhr, M.; Holsboer, F.: Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major-depression-A potential biomarker? Biological Psychiatry 62 (1), pp. 47 - 54 (2007)

Kern, N.; Erhardt, A.; Pfennig, A.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Uhr, M.; Holsboer, F. et al.; Binder, E. B.; Keck, M. E.: Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), p. 45 - 45 (2005)

Himmerich, H.; Fulda, S.; Künzel, H. E.; Pfennig, A.; Dzaja, A.; Cummings, D. E.; Pollmächer, T.: Ghrelin plasma levels during psychopharmacological treatment. Pharmacopsychiatry 38 (5), p. 249 - 249 (2005)

Ising, M.; Binder, E. B.; Dose, T.; Horstmann, S.; Kern, N.; Kloiber, S.; Künzel, H. E.; Lucae, S.; Pfennig, A.; Unschuld, P. G. et al.; Modell, S.; Holsboer, F.: Change in HPA system function predicts treatment response in depression. Pharmacopsychiatry 38 (5), p. 251 - 251 (2005)

Pfennig, A.; Künzel, H. E.; Kern, N.; Ising, M.; Majer, M.; Fuchs, B.; Ernst, G.; Holsboer, F.; Binder, E. B.: Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biological Psychiatry 57 (4), pp. 336 - 342 (2005)

Himmerich, H.; Fulda, S.; Künzel, H. E.; Pfennig, A.; Dzaja, A.; Cummings, D. E.; Pollmächer, T.: Ghrelin plasma levels during psychopharmacological treatment. Neuropsychobiology 52, pp. 11 - 16 (2005)

Kern, N.; Binder, E. B.; Pfennig, A.; Erhardt, A.; Ising, M.; Lucae, S.; Salyakina, D.; Pütz, B.; Holsboer, F.; Müller-Myhsok, B. et al.; Keck, M. E.: Possible association of angiotensin 1 converting enzyme polymorphisms with syndromal panic attacks. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), pp. 66 - 67 (2004)

Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. et al.; Nickel, T.; Künzel, H.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Löhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, pp. 1319 - 1325 (2004)

Künzel, H. E.; Binder, E. B.; Nickel, T.; Ising, M.; Fuchs, B.; Majer, M.; Pfennig, A.; Ernst, G.; Kern, N.; Schmid, D. A. et al.; Uhr, M.; Holsboer, F.; Modell, S.: Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28 (12), pp. 2169 - 2178 (2003)

Brunner, J.; Ising, M.; Binder, E. B.; Künzel, H. E.; Nickel, T.; Pfennig, A.; Kern, N.; Fuchs, B.; Majer, M.; Holsboer, F. et al.; Modell, S.: Prediction of response to antidepressant monotherapy. Pharmacopsychiatry 36 (5), p. 216 - 216 (2003)

Ising, M.; Adena, S. M.; Pfennig, A.; Binder, E. B.; Kern, N.; Huber, J.; Modell, S.; Holsboer, F.: Munich Vulnerability Study - Familial vulnerability for affective disorders: Search for endophenotypes. Pharmacopsychiatry 36 (5), p. 237 - 237 (2003)

Ising, M.; Binder, E.; Brunner, J.; Fuchs, B.; Kern, N.; Künzel, H. E.; Majer, M.; Nickel, T.; Pfennig, A.; Modell, S. et al.; Holsboer, F.: Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders. Pharmacopsychiatry 36 (5), p. 237 - 237 (2003)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), p. 239 - 239 (2003)

Pfennig, A.; Kuenzel, H. E.; Kern, N.; Fuchs, B.; Brunner, J.; Ising, M.; Modell, S.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.: HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 36 (5), pp. 252 - 253 (2003)